Annual Operating Expenses
$44.10 M
+$14.94 M+51.25%
December 31, 2023
Summary
- As of February 12, 2025, BLRX annual total operating expenses is $44.10 million, with the most recent change of +$14.94 million (+51.25%) on December 31, 2023.
- During the last 3 years, BLRX annual operating expenses has risen by +$21.17 million (+92.35%).
- BLRX annual operating expenses is now at all-time high.
Performance
BLRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$9.51 M
-$761.00 K-7.41%
September 1, 2024
Summary
- As of February 12, 2025, BLRX quarterly total operating expenses is $9.51 million, with the most recent change of -$761.00 thousand (-7.41%) on September 1, 2024.
- Over the past year, BLRX quarterly operating expenses has stayed the same.
- BLRX quarterly operating expenses is now -26.70% below its all-time high of $12.97 million, reached on December 31, 2023.
Performance
BLRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BLRX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.3% | 0.0% |
| 3 y3 years | +92.3% | 0.0% |
| 5 y5 years | +72.2% | 0.0% |
BLRX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.0% | -26.7% | +56.4% |
| 5 y | 5-year | at high | +92.3% | -26.7% | +104.5% |
| alltime | all time | at high | +186.2% | -26.7% | +294.0% |
BioLineRx Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.51 M(-7.4%) |
| Jun 2024 | - | $10.27 M(+0.5%) |
| Mar 2024 | - | $10.22 M(-21.2%) |
| Dec 2023 | $44.10 M(+51.3%) | $12.97 M(+5.0%) |
| Sep 2023 | - | $12.36 M(+24.6%) |
| Jun 2023 | - | $9.91 M(+12.0%) |
| Mar 2023 | - | $8.86 M(+5.5%) |
| Dec 2022 | $29.16 M(+17.7%) | $8.40 M(+18.6%) |
| Sep 2022 | - | $7.08 M(-6.9%) |
| Jun 2022 | - | $7.60 M(+25.1%) |
| Mar 2022 | - | $6.08 M(-7.9%) |
| Dec 2021 | $24.78 M(+8.1%) | $6.60 M(+6.1%) |
| Sep 2021 | - | $6.22 M(-4.5%) |
| Jun 2021 | - | $6.51 M(+19.5%) |
| Mar 2021 | - | $5.45 M(-7.2%) |
| Dec 2020 | $22.93 M(-18.4%) | $5.87 M(+26.3%) |
| Sep 2020 | - | $4.65 M(-16.5%) |
| Jun 2020 | - | $5.57 M(-18.6%) |
| Mar 2020 | - | $6.84 M(-27.3%) |
| Dec 2019 | $28.11 M(+9.8%) | $9.41 M(+41.7%) |
| Sep 2019 | - | $6.64 M(+2.6%) |
| Jun 2019 | - | $6.48 M(+16.1%) |
| Mar 2019 | - | $5.58 M(-20.7%) |
| Dec 2018 | $25.61 M(+1.4%) | $7.04 M(+13.3%) |
| Sep 2018 | - | $6.21 M(+8.5%) |
| Jun 2018 | - | $5.73 M(-13.6%) |
| Mar 2018 | - | $6.63 M(-13.8%) |
| Dec 2017 | $25.24 M | $7.69 M(+8.9%) |
| Sep 2017 | - | $7.06 M(+35.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $5.19 M(-2.0%) |
| Mar 2017 | - | $5.30 M(+20.9%) |
| Dec 2016 | $16.51 M(+2.0%) | $4.38 M(-2.3%) |
| Sep 2016 | - | $4.49 M(+16.1%) |
| Jun 2016 | - | $3.87 M(+2.4%) |
| Mar 2016 | - | $3.78 M(-7.9%) |
| Dec 2015 | $16.20 M(-6.1%) | $4.10 M(+13.8%) |
| Sep 2015 | - | $3.60 M(-13.5%) |
| Jun 2015 | - | $4.17 M(-3.7%) |
| Mar 2015 | - | $4.33 M(-16.7%) |
| Dec 2014 | $17.25 M(+1.5%) | $5.20 M(+27.7%) |
| Sep 2014 | - | $4.07 M(+4.1%) |
| Jun 2014 | - | $3.91 M(-4.0%) |
| Mar 2014 | - | $4.08 M(+68.9%) |
| Dec 2013 | $17.01 M(-22.1%) | $2.41 M(-25.7%) |
| Sep 2013 | - | $3.25 M(-29.3%) |
| Jun 2013 | - | $4.59 M(-29.3%) |
| Mar 2013 | - | $6.50 M(-7.0%) |
| Dec 2012 | $21.83 M(+41.7%) | $6.99 M(+40.5%) |
| Sep 2012 | - | $4.97 M(-2.2%) |
| Jun 2012 | - | $5.09 M(-0.4%) |
| Mar 2012 | - | $5.11 M(+21.9%) |
| Dec 2011 | $15.41 M(-26.6%) | $4.19 M(-7.1%) |
| Sep 2011 | - | $4.51 M(+2.4%) |
| Jun 2011 | - | $4.40 M(+53.3%) |
| Mar 2011 | - | $2.87 M(-49.0%) |
| Dec 2010 | $20.98 M | $5.63 M(+91.7%) |
| Sep 2010 | - | $2.94 M(-63.0%) |
| Jun 2010 | - | $7.94 M(+101.4%) |
| Mar 2010 | - | $3.94 M |
FAQ
- What is BioLineRx annual total operating expenses?
- What is the all time high annual operating expenses for BioLineRx?
- What is BioLineRx annual operating expenses year-on-year change?
- What is BioLineRx quarterly total operating expenses?
- What is the all time high quarterly operating expenses for BioLineRx?
- What is BioLineRx quarterly operating expenses year-on-year change?
What is BioLineRx annual total operating expenses?
The current annual operating expenses of BLRX is $44.10 M
What is the all time high annual operating expenses for BioLineRx?
BioLineRx all-time high annual total operating expenses is $44.10 M
What is BioLineRx annual operating expenses year-on-year change?
Over the past year, BLRX annual total operating expenses has changed by +$14.94 M (+51.25%)
What is BioLineRx quarterly total operating expenses?
The current quarterly operating expenses of BLRX is $9.51 M
What is the all time high quarterly operating expenses for BioLineRx?
BioLineRx all-time high quarterly total operating expenses is $12.97 M
What is BioLineRx quarterly operating expenses year-on-year change?
Over the past year, BLRX quarterly total operating expenses has changed by $0.00 (0.00%)